Canadian Journal Addiction Medicine - Canadian Harm Reduction ...

Table III: Reported naloxone use among 50 Edmonton area opioid users after 1 year of a pilot project
Variable N (%)
Recipient:
A friend
An acquaintance
My partner
A stranger
Myself
Location of Use:
Private Residence
Other
On the street
Drugs involved in the overdose *
Opioid
Cocaine/Crack
Other drugs
Alcohol
*
Totals N>9 due to more than one drug being involved in some overdoses.
3 (33%)
3 (33%)
1 (11%)
1 (11%)
1 (11%)
4 (44%)
3 (33%)
2 (22%)
9 (100%)
4 (44%)
2 (22%)
1 (11%)
Table IV: Comparison of Participant Drug Use Before and After Naloxone Training
Drug Baseline (N) * Exit (N) p-value
Opioids:
Heroin
Morphine
Hydromorphone
Codeine
Oxycodone
Propoxyphene
Methadone
Stimulants:
Crack
Cocaine
Methamphetamines
Others:
Benzodiazepines
Marijuana
Alcohol
3
13
8
9
12
2
7
14
8
5
13
7
8
*
N represents the number of people who reported regular use during the last six months.
3
7
4
8
7
1
8
12
3
1
8
8
9
1.0
0.05
0.26
1.0
0.12
0.60
1.0
0.13
0.60
0.17
0.11
1.0
1.0
References
November 2012
Patra J, Taylor B, Rehm JT, Baliunas D, Popova S. Substanceattributable
morbidity and mortality changes to Canada’s
epidemiological profile: measurable differences over a ten-year
period. Can J Public Health 2007;98(3):228-34.
Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al.
The costs of alcohol, illegal drugs, and tobacco in Canada, 2002.
J Stud Alcohol Drugs 2007;68(6):886-95.
Popova S, Rehm J, Fischer B. An overview of illegal opioid use
and health services utilization in Canada. Public Health
2006;120(4):320-8.
Fischer B, Rehm J, Goldman B, Popova S. Non-medical use of
prescription opioids and public health in Canada: an urgent call
for research and interventions development. Can J Public Health
2008;99(3):182-4.
Currie CL, Schopflocher DP, Wild TC. Prevalence and correlates of
12-month prescription drug misuse in Alberta. Can J Psychiatry
2011;56(1):27-34.
Hsu W, Rao RB, Nelson LS. Naloxone hazards overstated. J Toxicol
Clin Toxicol 1997;35(2):215-7.
Sporer KA, Kral KH. Prescription naloxone: a novel approach to heroin
overdose prevention. Ann Emerg Med 2007;49(2):172-7.
Baca CT, Grant KJ. Take-home naloxone to reduce heroin death.
Addiction 2005;100(12):1823-31.
8